New oral anticoagulants increase GI bleeding riskAnalysis included studies that compared new oral anticoagulants to standard care; all studies had to include data on bleeding events. Niacin prescriptions rise despite questionable benefitPhysicians should reconsider the role of the drug in the wake of negative trials, researcher says MI prevention: We could be doing better Screening for risk factors is not optimal Cardioviva: new probiotic modestly lowers cholesterol New cholesterol-reducing probiotic marketed as a natural health product. Water protects the kidney but not the heart High intake linked with lower chronic renal disease risk New Indication for Xarelto: Pulmonary Embolism (PE) Treatment The incidence of PE in Canada has increased significantly due to the widespread availability and sensitivity of equipment used to diagnose this illness. Water protects the kidney but not the heart High intake linked with lower chronic renal disease risk Cell therapy for heart attack: Results still mixed Recent trials enrolled patients days or years after suffering an MI Gut bugs brew trouble Leading edge Toronto Ottawa Heart Summit adds primary care perspective to June agenda First Previous 58 59 60 61 62 Next Last
